Augmenter of liver regeneration: Its place in the universe of hepatic growth factors

Hepatology

Volumn 20, Issue 3, 1994, Pages 747-757

  Francavilla, Antonio ^a   Hagiya, Michio ^b   Porter, Kendrick A ^a   Polimeno, Lorenzo ^a   Ihara, Izumi ^b   Starzl, Thomas E ^c,d  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b TOYOBO CO LTD   (Japan)

^c UNIVERSITY OF BARI   (Italy)

^d ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACR F4; CYCLOSPORIN; GROWTH FACTOR; INSULIN; RAPAMYCIN; RECOMBINANT AUGMENTER OF LIVER REGENERATION; SOMATOMEDIN B; TACROLIMUS; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; HORMONE ACTION; LIVER REGENERATION; LIVER RESECTION; NONHUMAN; PATHOPHYSIOLOGY; PORTOCAVAL SHUNT; PRIORITY JOURNAL; PROTEIN PURIFICATION; REVIEW;

AMINO ACID SEQUENCE; ANIMAL; GROWTH SUBSTANCES; HUMAN; LIVER; MOLECULAR SEQUENCE DATA; PORTACAVAL SHUNT, SURGICAL; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027930477     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.1840200328     Document Type: Article

References (94)

1. The effect of Eck and reverse Eck fistula in dogs with experimental diabetes mellitus
2. Effect in dogs of various portal vein shunts on response to insulin
3. Effect of insulin on glucose metabolism in the dog after portacaval transposition
4. Die Eck'sche Fistel zwischen der unteren Hohlvene und der Pfortader und ihre Folgen fur den Organismus
5. The animal with an Eck fistula
6. Reconstructive problems in canine liver homotransplantation with special reference to the postoperative role of hepatic venous flow
7. Immunosuppression after experimental and clinical homotransplantation of the liver
8. Physiologic requirements for auxiliary liver homotransplantation
9. The effect of partial portacaval transposition on the canine liver
10. The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood
11. Intraportal insulin protects from the liver injury of portacaval shunt in dogs
12. Growth‐stimulating factor in regenerating canine liver
13. Extraction of hepatic stimulatory activity (HSA) from (adult) rat liver following T3 injection (Abstract)
14. Extraction and partial purification of hepatic stimulatory substance in rats, mice and dogs
15. Further steps of HSS (hepatic stimulatory substance) purification
16. Hepatic regeneration and growth factors
17. Cloning and sequence analysis of the rat augmenter of liver regeneration (ALR) gene: expression of biologically active recombinant ALR and demonstration of tissue distribution
18. Screening for candidate hepatic growth factors by selective portal infusion after canine Eck fistula
19. The hepatotrophic influence of cyclosporine
20. Hepatotrophic effects of FK 506 in dogs
21. Hepatotrophic properties in dogs of human FKBP, the binding protein for FK 506 and rapamycin
22. The effect on the canine Eck fistula liver of intraportal TGF‐Beta alone or with hepatic growth factors
23. Inhibition of liver, kidney and intestine regeneration by rapamycin
24. K voprosu o perevyazkie vorotnois veni: Predvaritelnoye soobschjenye
25. A note on transplantation of the whole liver in dogs
26. Dual function of a new nuclear gene for oxidative phosphorylation and vegetative growth in yeast
27. Hemopoietic growth factors: A review
28. Clinical implications of positive and negative hematopoietic stem cell regulators
29. Granulocyte colony‐stimulating factor and granulocyte‐macrophage colony‐stimulating factor
30. Receptor‐mediated gene delivery in vivo. Partial correction of genetic analbuminemia in Nagase rats
31. The influence of portal blood upon lipid metabolism in normal and diabetic dogs and baboons
32. Hepatic encephalopathy and light electron micrographic changes of the baboon liver after portal diversion
33. The Eck fistula in animals and humans
34. Effects of insulin, glucagon, and insulin/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs
35. Liver cell damage produced by portacaval shunt
36. Portal hepatotrophic factors, diabetes mellitus and acute liver atrophy, hypertrophy and regeneration
37. L'Anastomose porto‐cave experimentale chez le rat normal
38. Anastomose portocave latero‐laterale experimentale
39. The effect of diabetes mellitus on portal blood hepatotrophic factors in dogs
40. Fine structural and growth characteristics of cultured rat liver cells: insulin effects
41. Hormonal stimulation of DNA synthesis in primary cultures of adult rat hepatocytes
42. Effect of insulin on ultrastructure and glycogenesis in primary cultures of adult rat hepatocytes
43. The effect of splanchnic viscera removal upon canine liver regeneration
44. The effect upon the liver of evisceration with or without hormone replacement
45. Induction of deoxyribonucleic acid synthesis in the liver of the intact animal
46. Specific endocrine and hormonal receptor changes associated with liver regeneration in adult rats
47. Control of growth of mammalian cells in cell culture
48. Regulation of hepatic regeneration in rats by synergistic action of insulin and glucagon
49. Liver regeneration studies with rat hepatocytes in primary culture
50. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats
51. Hepatotrophic substances
52. Experimental pathology of liver
53. Homologous liver as a stimulus to hepatic regeneration
54. Mitotic activity and growth factors in the liver of the whole rat
55. Growth stimulation in the liver and tumor development following intraperitoneal injections of liver homogenates in the rat
56. Preparation and partial characterization of hepatic regenerative stimulator substance (HSS) from rat liver
57. Stimulation of hepatic regeneration after partial hepatectomy by infusion of a cytosol extract from regeneration dog liver
58. Liver regeneration in dogs: morphologic and chemical changes
59. Inter‐organ communications: with particular reference to hepatotrophic factors and intrinsic liver growth factors
60. The effect of hepatic stimulatory substance isolated from regenerating hepatic cytosol and 50,000 and 30,000 subfractions in enhancing survival in experimental acute hepatic failure in rats treated with d‐Galactosamine
61. 3 and appearance of the activity despite inhibition of DNA synthesis by adriamycin
62. Purification and physical‐chemical characterization of hepatic stimulator substance
63. Purification of hepatic stimulator substance(ss) to homogeneity [Abstract]
64. Partial purification of rat hepatic stimulator substance and characterization of its action on hepatoma cells and normal hepatocytes
65. Deletion of kringle domains or the N‐terminal hairpin structure in hepatocyte growth factor results in marked decreases in related biological activities
66. Rat transforming growth factor type I: structure and relation to epidermal growth factor
67. The effect of cyclosporine on hepatic regeneration
68. Augmentation of rat liver regeneration by FK 506 compared with cyclosporine
69. Contempo 90: Transplantation
70. The mechanism of action of cyclosporin A and FK 506
71. Chemistry and biology of the immunophilins and their immunosuppressive ligands
72. r 90,000 heat shock protein: Main structural features of a mammalian p59 protein
73. Leukocyte chemotactic activity of cyclophilin
74. Rapamycin‐FKBP specifically blocks growth‐dependent activation of and signaling by the 70 kd S6 protein kinases
75. Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK 506 and rapamycin
76. Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin
77. Effects of rapamycin (RPM) on cultured hepatocyte proliferation and gene expression
78. Nucleo‐mitochondrial interaction in yeast mitochondrial biogenesis
79. The immediate early‐growth response in regenerating liver and insulin‐stimulated H‐35 cells; comparison with serum‐stimulated 3T3 cells and identification of 41 novel immediate‐early genes
80. Genetic regulatory mechanisms in the synthesis of proteins
81. Proliferation of hepatocytes
82. Liver regeneration: molecular mechanisms of growth control
83. Regeneration
84. Hepatic regeneration
85. Expression and phosphorylation of insulin receptor substrate 1 during rat liver regeneration
86. Regulation of insulin receptor functions by a peptide derived from a major histocompatibility complex class I antigen
87. In vivo response of hepatocytes to growth factors requires an initial priming stimulus
88. How receptors turn Ras on
89. Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway
90. Augmentation of cell‐mediated cytotoxicity following 50% partial hepatectomy
91. Effect of cyclosporin A on liver regeneration following partial hepatectomy in the mouse
92. Interferon‐y inhibits liver regeneration by stimulating major histocompatibility complex class II antigen expression by regenerating liver